Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tagrisso is also approved to treat NSCLC with EGFR mutations in the first line metastatic setting as a monotherapy and in combination with chemotherapy, and as an adjuvant treatment for early-stage disease
covered the drugs in 2024, according to a 2024 survey from Mercer
Your personalized wellness journey begins at Premier Health & Wellness!
Many patients with partial tears or chronic tendinopathy experience significant improvement within 8-12 weeks
You have to start with the lowest dose and make sure your body tolerates it before moving up to a higher dose
US$ 22.49
US$ 27.91
US$ 21.23
US$ 23.03
US$ 26.72
US$ 21.81
